Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

Healthcare Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Medipharm Labs Corp
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(603)
•••
Post by subaru1ion Mar 22, 2024 8:36am
101 Views
Post# 35946657

Does it make sense now why LABS in December executed

Does it make sense now why LABS in December executedthis not only for 2023 but ALSO for 2024

The Company also announced today that in accordance with its annual Long Term Incentive Plan ("LTIP") it has granted, effective December 22, 2023 , 15.48 million stock options and 16.09 million restricted share units (both each, a "Unit"). 

 The award to certain directors, officers and employees of the Company was related to the Company's LTIP program for 2023 and 2024.


So back in December,  LABS was already confident as was their global pharma partner that the DEA would reschedule from 1 to 3 within 2024.

...rags to ritches.....enjoy...who is he talking too on the screen? Example of Athea :-)




<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities